The Food and Drug Administration (FDA) has approved a new HIV drug.
Genvoya was approved to treat adults and teenagers living with human immunodeficiency virus, which causes AIDS, the FDA announced Thursday.
Genvoya is a complete regimen that proved just as effective at treating HIV in clinical trials as similar drugs. The most common side effect was nausea.
The HIV drug contains elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.
According to the Centers for Disease Control, more than 1.3 million people have HIV in the United States.